BioPharm International
March 01, 2012
Issue PDF
25
3
Scale-Up of Human Stem Cells
March 01, 2012
Features
25
3
Demonstration of large-scale stem-cell scale-up.
March 01, 2012
Features
25
3
Recombinant albumin can stabilize a drug product and assist in API release.
March 01, 2012
Final Word
25
3
Does global development have to entail multiple comparability studies?
March 01, 2012
Regulatory Beat
25
3
Social media use raises questions about applying old standards to new information technology.
March 01, 2012
Boot Camp Business Guide
25
3
Key business considerations when developing biosimilar products virtually.
March 01, 2012
Perspectives on Outsourcing
25
3
The evolving bio/pharmaceutical business model poses risk for CMOs.
March 01, 2012
From the Editor
25
3
Has the long-awaited guidance answered all of the industry's questions?
March 01, 2012
Features
25
3
The authors compare the exposure risk from viable particles from the air supply in four well-established aseptic filling technologies.
March 01, 2012
Compliance Notes
25
3
Focusing on how risk affects the entire organization can improve the business bottom line.
March 01, 2012
Features
25
3
This month, we rewind to an article titled "Demystifying the New Biology."
March 01, 2012
Boot Camp Tech Guide
25
3
Key technical considerations when developing a clinical project in the biotech world.